Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Endometrial Neoplasms" (139 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer
Condition: Endometrial Neoplasm
Intervention: Procedure: Sentinel lymph node mapping
2 Recruiting Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Drug: Paclitaxel;   Drug: MLN0128;   Drug: MLN1117
3 Recruiting Sentinel Lymph Node Detection in Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel node procedure
4 Recruiting Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel lymph node biopsy
5 Recruiting The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Procedure: TH;   Procedure: TH/BSO;   Procedure: BPLND
6 Recruiting STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Extraperitoneal Laparoscopic aortic lymphadenectomy;   Procedure: Transperitoneal Laparoscopic aortic lymphadenectomy
7 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
8 Recruiting Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Conditions: Uterine Neoplasms;   Endometrial Neoplasms
Intervention:
9 Recruiting LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma
Conditions: Cancer of Endometrium;   Carcinoma of Endometrium;   Endometrial Neoplasms
Intervention: Procedure: Lavage of the Uterus
10 Recruiting Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
Conditions: Lynch Syndrome;   Endometrial Neoplasms;   Ovarian Neoplasms;   Colorectal Neoplasms
Intervention: Behavioral: Questionnaire, Educational Material
11 Not yet recruiting Endometrial Cancer Diet and Exercise
Condition: Early Stage Endometrial Cancer
Intervention: Behavioral: Home-based aerobic exercise and nutritional counseling
12 Not yet recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
13 Recruiting Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Condition: Recurrent Endometrial Cancer
Intervention: Drug: Pembrolizumab
14 Not yet recruiting Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.
Condition: Progesterone Induced Blocking Factor in Endometrial Cancer
Intervention:
15 Recruiting Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Procedure: Sentinel Lymph Node Dissection, Firefly
16 Recruiting SLNM in Endometrial Cancer Combined With OSNA
Condition: Endometrial Cancer
Intervention: Device: RD-100i, OSNA
17 Not yet recruiting Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine
Condition: Endometrial Cancer
Intervention:
18 Recruiting A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
Condition: Endometrial Cancer
Intervention: Drug: Atorvastatin
19 Recruiting Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY
Condition: Endometrial Cancer
Interventions: Device: Clermont-Ferrand Uterine Manipulator;   Other: No uterine Manipulator
20 Not yet recruiting Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients
Condition: Recurrent Endometrial Cancer
Interventions: Drug: Olaparib;   Drug: metformin;   Drug: metronomic cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.